Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal
© 2016 Wiley Periodicals, Inc..
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccination response in children are unknown in Kwazulu-Natal. This study included 183 HIV-infected and 108 HIV-uninfected children aged between 5 and 15 years screened for HBV infection and vaccination. HBV infection occurred in 2.1% and 0% of HIV-infected and uninfected children respectively. Serological response to immunization was shown in 15.8% and 61.1% of HIV-infected and uninfected children, respectively (P < 0.001). Even if prevalence of HBV infection was low in these cohorts, HIV-infected children will stay at risk of infection if the vaccine schedule is not adapted. J. Med. Virol. 89:182-185, 2017. © 2016 Wiley Periodicals, Inc.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:89 |
---|---|
Enthalten in: |
Journal of medical virology - 89(2017), 1 vom: 15. Jan., Seite 182-185 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Beghin, Jean-Christophe [VerfasserIn] |
---|
Links: |
---|
Themen: |
Chronic hepatitis B |
---|
Anmerkungen: |
Date Completed 07.09.2017 Date Revised 11.06.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jmv.24598 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM26130688X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM26130688X | ||
003 | DE-627 | ||
005 | 20231224195257.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jmv.24598 |2 doi | |
028 | 5 | 2 | |a pubmed24n0871.xml |
035 | |a (DE-627)NLM26130688X | ||
035 | |a (NLM)27291342 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Beghin, Jean-Christophe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effectiveness of the South African expanded program of immunization against hepatitis B in children infected with human immunodeficiency virus-1 living in a resource-limited setting of Kwazulu-Natal |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.09.2017 | ||
500 | |a Date Revised 11.06.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2016 Wiley Periodicals, Inc. | ||
520 | |a Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccination response in children are unknown in Kwazulu-Natal. This study included 183 HIV-infected and 108 HIV-uninfected children aged between 5 and 15 years screened for HBV infection and vaccination. HBV infection occurred in 2.1% and 0% of HIV-infected and uninfected children respectively. Serological response to immunization was shown in 15.8% and 61.1% of HIV-infected and uninfected children, respectively (P < 0.001). Even if prevalence of HBV infection was low in these cohorts, HIV-infected children will stay at risk of infection if the vaccine schedule is not adapted. J. Med. Virol. 89:182-185, 2017. © 2016 Wiley Periodicals, Inc | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a HIV/HBV co-infection | |
650 | 4 | |a chronic hepatitis B | |
650 | 4 | |a long-term outcome | |
650 | 4 | |a resource-limited setting | |
650 | 7 | |a Hepatitis B Vaccines |2 NLM | |
700 | 1 | |a Ruelle, Jean |e verfasserin |4 aut | |
700 | 1 | |a Sokal, Etienne |e verfasserin |4 aut | |
700 | 1 | |a Bachy, Antoine |e verfasserin |4 aut | |
700 | 1 | |a Krishna, Malini |e verfasserin |4 aut | |
700 | 1 | |a Hall, Leslie |e verfasserin |4 aut | |
700 | 1 | |a Goubau, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Van der Linden, Dimitri |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 89(2017), 1 vom: 15. Jan., Seite 182-185 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
773 | 1 | 8 | |g volume:89 |g year:2017 |g number:1 |g day:15 |g month:01 |g pages:182-185 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.24598 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 89 |j 2017 |e 1 |b 15 |c 01 |h 182-185 |